Alligator Bioscience AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2023-06-09 | Alligator Bioscience AB | Peter Ellmark | Other member of the company's administrative, management or supervisory body | Acquisition | 600 000 | 0,06 | SEK | 36 000 | 2023-06-06 |
| 2023-06-09 | Alligator Bioscience AB | Søren Bregenholt Frederiksen | Chief Executive Officer (CEO)/Managing Directory | Disposal | 5 900 000 | 0,06 | SEK | 354 000 | 2023-06-06 |
| 2023-06-09 | Alligator Bioscience AB | Søren Bregenholt Frederiksen | Chief Executive Officer (CEO)/Managing Directory | Disposal | 1 440 000 | 0,06 | SEK | 86 400 | 2023-06-06 |
| 2023-06-09 | Alligator Bioscience AB | Peter Ostler | Member of the Board of Directors | Acquisition | 240 000 | 0,06 | SEK | 14 400 | 2023-06-06 |
| 2023-06-09 | Alligator Bioscience AB | Veronica Wallin | Member of the Board of Directors | Acquisition | 240 000 | 0,06 | SEK | 14 400 | 2023-06-06 |
| 2023-06-09 | Alligator Bioscience AB | Anders Ekblom | Chairman of the Board of Directors | Acquisition | 240 000 | 0,06 | SEK | 14 400 | 2023-06-06 |
| 2023-06-22 | Alligator Bioscience AB | Marie Svensson | Chief Financial Officer (CFO) | Acquisition | 18 333 | 0,13 | SEK | 2 383,29 | 2023-06-19 |
| 2023-09-04 | Alligator Bioscience AB | Marie Svensson | Chief Financial Officer (CFO) | Exercise decrease | 170 000 | 0 | SEK | 0 | 2023-08-30 |
| 2023-09-04 | Alligator Bioscience AB | Marie Svensson | Chief Financial Officer (CFO) | Exercise increase | 21 250 | 0,4 | SEK | 8 500 | 2023-08-30 |
| 2023-09-04 | Alligator Bioscience AB | Sören Bregenholt Frederiksen | Chief Executive Officer (CEO)/Managing Directory | Exercise decrease | 558 896 | 0,05 | SEK | 27 944,8 | 2023-08-30 |
| 2023-09-04 | Alligator Bioscience AB | Sören Bregenholt Frederiksen | Chief Executive Officer (CEO)/Managing Directory | Exercise increase | 69 865 | 0,4 | SEK | 27 946 | 2023-08-30 |
| 2023-09-04 | Alligator Bioscience AB | Anders Ekblom | Chairman of the Board of Directors | Exercise increase | 23 293 | 0,4 | SEK | 9 317,2 | 2023-08-30 |
| 2023-09-04 | Alligator Bioscience AB | Anders Ekblom | Chairman of the Board of Directors | Exercise decrease | 186 344 | 0,05 | SEK | 9 317,2 | 2023-08-30 |
| 2023-09-04 | Alligator Bioscience AB | Staffan Encrantz | Member of the Board of Directors | Acquisition | 16 688 551 | 0,4 | SEK | 6 675 420,4 | 2023-08-30 |
| 2023-09-04 | Alligator Bioscience AB | Staffan Encrantz | Member of the Board of Directors | Disposal | 133 508 406 | 0,05 | SEK | 6 675 420,3 | 2023-08-30 |
| 2023-10-31 | Alligator Bioscience AB | Marie Svensson | Chief Financial Officer (CFO) | Acquisition | 600 000 | 0,06 | SEK | 36 000 | 2023-10-30 |
| 2023-10-31 | Alligator Bioscience AB | Marie Svensson | Chief Financial Officer (CFO) | Acquisition | 70 000 | 0,06 | SEK | 4 200 | 2023-10-30 |
| 2023-10-31 | Alligator Bioscience AB | Marie Svensson | Chief Financial Officer (CFO) | Acquisition | 250 000 | 0,13 | SEK | 32 500 | 2023-10-30 |
| 2024-03-04 | Alligator Bioscience AB | Marie Svensson | Chief Financial Officer (CFO) | Acquisition | 16 667 | 0,13 | SEK | 2 166,71 | 2024-02-28 |
| 2024-03-04 | Alligator Bioscience AB | Marie Svensson | Chief Financial Officer (CFO) | Acquisition | 95 000 | 0,06 | SEK | 5 700 | 2024-02-28 |